Polylactic acid (PLA) controlled delivery carriers for biomedical applications

B Tyler, D Gullotti, A Mangraviti, T Utsuki… - Advanced drug delivery …, 2016 - Elsevier
Polylactic acid (PLA) and its copolymers have a long history of safety in humans and an
extensive range of applications. PLA is biocompatible, biodegradable by hydrolysis and …

[HTML][HTML] Applications of synthetic polymers in clinical medicine

MF Maitz - Biosurface and Biotribology, 2015 - Elsevier
Multiple biological, synthetic and hybrid polymers are used for multiple medical applications.
A wide range of different polymers is available, and they have further the advantage to be …

[HTML][HTML] Five-year outcomes after PCI or CABG for left main coronary disease

GW Stone, AP Kappetein, JF Sabik… - … England Journal of …, 2019 - Mass Medical Soc
Background Long-term outcomes after percutaneous coronary intervention (PCI) with
contemporary drug-eluting stents, as compared with coronary-artery bypass grafting …

Everolimus-eluting stents or bypass surgery for left main coronary artery disease

GW Stone, JF Sabik, PW Serruys… - … England Journal of …, 2016 - Mass Medical Soc
Background Patients with obstructive left main coronary artery disease are usually treated
with coronary-artery bypass grafting (CABG). Randomized trials have suggested that drug …

Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical …

F Gijsen, Y Katagiri, P Barlis, C Bourantas… - European heart …, 2019 - academic.oup.com
Expert recommendations on the assessment of wall shear stress in human coronary arteries:
existing methodologies, technical considerations, and clinical applications | European Heart …

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …

JP Collet, H Thiele, E Barbato… - European heart …, 2021 - academic.oup.com
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease: meta-analysis of …

S Bangalore, B Toklu, N Patel, F Feit, GW Stone - Circulation, 2018 - Am Heart Assoc
Background: Contemporary second-generation drug-eluting stents (DES) have superior
efficacy and safety in comparison with early-generation stents in patients undergoing …

Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

T Palmerini, U Benedetto, G Biondi-Zoccai… - Journal of the American …, 2015 - jacc.org
Background: Previous meta-analyses have investigated the relative safety and efficacy
profiles of different types of drug-eluting stents (DES) and bare-metal stents (BMS); however …

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation …

DE Kandzari, L Mauri, JJ Koolen, JM Massaro, G Doros… - The Lancet, 2017 - thelancet.com
Background The development of coronary drug-eluting stents has included use of new metal
alloys, changes in stent architecture, and use of bioresorbable polymers. Whether these …

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

MR Patel, MS Conte, DE Cutlip, N Dib… - Journal of the American …, 2015 - jacc.org
The lack of consistent definitions and nomenclature across clinical trials of novel devices,
drugs, or biologics poses a significant barrier to accrual of knowledge in and across …